North Central London
Joint Formulary
 
back
5 Infections

Prescribing of systemic antimicrobials is 'protected'. All prescribing MUST be in accordance with the Trust Antimicrobial Policy and in conjunction with local antimicrobial guideline:

05-01-07 Some other antibacterials

Dalbavancin infusion
Restricted

Approved if recommended by Microbiology for skin and soft tissue infections in patients only if (JFC April 2017):

  • unable to receive oral therapy and
  • available treatment pathways for repeated IV antibiotics are unsuitable e.g. chaotic lifestyle, immobility, poor venous access

Provider notes

  • NMUH:
    • On microbiology recommendation only
  • RFL:
    • Restricted to Microbiology Consultant only
  • RNOH:
    • Non-formulary
  • UCLH:
    • Skin and soft tissue infections in patients unable to receive oral therapy- Restricted to Microbiology recommendation (JFC April 2017)
  • WH:
    • As above (restricted to Microbiology)

Restricted Drug GP - Red View adult BNF  View SPC online  View childrens BNF
Rifaximin Xifaxanta®
Restricted

Approved for small intestine bacterial overgrowth (SIBO) in patients with systemic sclerosis (SSc) only (JFC June 2019)

Provider notes

  • NMUH:
    • Approved for use in the treatment of small intestinal bacterial overgrowth (SIBO) in systemic sclerosis (SSc) patients only
  • RFL:
    • Approved for use in the treatment of small intestinal bacterial overgrowth (SIBO) in systemic sclerosis (SSc) patients only
  • RNOH:
    • Non-formulary
  • UCLH:
    • Non-formulary
  • WH:
    • Approved for use in the treatment of small intestinal bacterial overgrowth (SIBO) in systemic sclerosis (SSc) patients only

Restricted Drug GP - Red View adult BNF  View SPC online  View childrens BNF
Oritavancin Orbactiv®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Tedizolid
Non Formulary

View adult BNF  View SPC online  View childrens BNF